tradingkey.logo

AstraZeneca wins shareholder backing for NYSE listing as drugmaker pivots to US

ReutersNov 3, 2025 4:02 PM

- AstraZeneca AZN.L shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving it access to a deeper capital pool.

AstraZeneca said 99.36% of votes cast in a general meeting favoured the proposal. The company needed at least 75% of votes for the resolution to pass.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI